Strategic Planning and Communication of Evidence (SPACE™)
It is important that effective Integrated Evidence Planning takes place at an early stage in the product lifecycle, to proactively plan the generation of value evidence in a strategic manner with cross functional teams – bridging clinical, medical, commercial, health economics and outcomes, and access teams.
The Adelphi Values PROVE™ SPACE™ approach has been developed based on our proprietary knowledge built on our years of experience in guiding clients on evidence needs and our long-standing tried and tested modular approach to strategic planning. This is a robust framework which can be applied across multiple therapy areas and products.
The Adelphi Values PROVE™ SPACE™ approach offers:
Synergy: Improves cooperation, bringing together all the evidence planning taking place among the various functions in the asset, regional, brand and research teams.
Collaboration: Creates understanding, building on the participation of a broader range of functions, regions, and customer-facing groups, establishing a collective understanding of the evidence needed by customers and the team’s plans to generate rigorous and impactful data.
Clarity: Defines purpose, mapping the evolution of customer decisions, value propositions, evidence requirements, internal and external data opportunities, and the decisions as the team plans and the competitive market landscape and access opportunities change.
Discipline: Provides the robust framework for making disciplined trade-off decisions on evidence generation and a record of the team’s thinking and governance body decisions.
Value Insight & Communiction
Click here for details of our wider expertise and our database of published research and conference presentations